Mass Tort News

Latest Mass Tort Litigation News

CHINESE MEDICAL STUDY ON COVID-19 THAT WAS REMOVED BY CHINESE GOVERNMENT ON MARCH 25, 2020

COVID-19 April 16, 2020

Study Title: Clinical Characteristics of Coronavirus Disease 2019 in China (references included) Fudan University Link:  https://web.archive.org/web/20200409053204/http://www.it.fudan.edu.cn/Data/View/3657 CONCLUSIONS: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health […]

FDA Issues Recall Statement On All Zantac (Ranitidine) Products

Zantac April 1, 2020

FDA NEWS RELEASE FDA Requests Removal of All Ranitidine Products (Zantac) from the Market FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk  The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the […]

Purdue Pharma and the Sackler Family Created the Opioid Crisis in America: “The Oxy Express”

Opioid Crisis February 5, 2020

Why are the Sacklers worth $13 billion today? “The Oxy Express” explained. See Richard Sackler’s Unsealed Deposition Transcript in Kentucky vs. Purdue Pharma (2015). See Purdue Frederick Co. (not Purdue Pharma) Criminal Guilty Plea Outline May 9, 2007 (USDC Virginia). Mass Tort News February 4, 2020 COMPARISON OF OXYCODONE PRESCRIBING In the first six months […]

LITIGATION FUNDING FORUM MARCH 26, 2020 New York City

Uncategorized February 3, 2020

LITIGATION FUNDING: DON’T GET LEFT BEHIND www.litigationfundingforum.com (MASS TORT NEWS)  It has now become a common practice for law firms, both plaintiff and defense to utilize outside financial resources to support not only litigation, but the overall legal practice in law firms  and law departments across the United States. As is continuously stated, “he who […]

Rudy Giuliani Was DC Back-Office Fixer That Let Purdue Pharma (OxyContin) Slip Out Of A 2006 Criminal Indictment

Opioid Crisis January 31, 2020

Richard Sackler Unsealed Deposition Transcript in Kentucky vs. Purdue: https://www.documentcloud.org/documents/5745212-Deposition.html (2015) See the Purdue Frederick Co. (not Purdue Pharma) Criminal Guilty Plea Outline May 9, 2007 (USDC Virginia) How was Purdue Pharma able to slip through the 2006 criminal indictment noose and continue to market, sell and prescribe Oxycontin for another 10 years? Giuliani and GW […]

Nuedexta: Drug Being Pushed “Off-Label” On Elderly In Nursing Homes = $116 Million Settlement

Current Litigation January 7, 2020

Avanir Pharmaceuticals, the maker of Nuedexta, a prescription drug approved to treat a rare neurological condition is earning hundreds of millions of dollars a year  by aggressively targeting elderly nursing home residents in “off-label” use, for whom the drug may be unnecessary and now recognized as unsafe. Off-label use is when a company offers and […]

JUUL: How Big Tobacco bought into a company that killed teens for profit!

Current Litigation , JUUL December 27, 2019

The FDA missed a deadly corporate marketing campaign–AGAIN! Juul’s popularity was fueled by the company’s social media marketing that featured attractive young people in fun, trendy settings. A report by Stanford University researchers concluded that Juul’s launch marketing was “patently youth oriented” and “subsequently Juul’s principal advertising themes have been closely aligned with that of traditional tobacco advertising.” Why […]

Why Does the FDA Ignore “Off-Label” Drug Marketing While Thousands Die Every Year?

Current Litigation , Opioid Crisis October 19, 2019

Profits Before Patients is the FDA-Big Pharma Shared Model “BY REMOVING FDA OVERSIGHT BIG PHARMA WAS ALLOWED TO PROFIT FROM LIES” (October 19, 2019) (MASS TORT NEWS)  Starting in 2017 and continuing into the foreseeable future, Big Pharma has been fighting major legal battles related to off-label marketing of drugs for unintended uses. They also […]